Silodosin is an active pharmaceutical ingredient used as an alpha-1 adrenergic receptor antagonist. It is primarily supplied for the symptomatic management of benign prostatic hyperplasia in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 160970-54-7
Desisopropyl butyl torsemide
pharmaceutical raw material
Cromoglicic acid
pharmaceutical raw material
Bictegravir
pharmaceutical raw material
3b-17-Imino-androst-5-en-3-ol Acetate Dimer
pharmaceutical raw material
(R/S)-silodosin
pharmaceutical raw material
1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide
PNCPYILNMDWPEY-QGZVFWFLSA-N
C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F